Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair

Kortekaas, K.A.; Baan, A. van der; Aarts, L.P.H.J.; Palmen, M.; Cobbaert, C.M.; Verhagen, J.C.M.; ... ; Lindeman, J.H.N. (2014)

Article / Letter to editor

• anaesthetics volatile
• sevoflurane
• cardiopulmonary bypass
• immune response
• myocardial damage
• reperfusion injury

• All authors: Kortekaas, K.A.; Baan, A. van der; Aarts, L.P.H.J.; Palmen, M.; Cobbaert, C.M.; Verhagen, J.C.M.; Engbers, F.H.M.; Klautz, R.J.M.; Lindeman, J.H.N.
• Date: 2014-06-30
• Journal: British Journal of Anaesthesia
• Volume: 112
• Issue: 6
• Pages: 1005 - 1014
• DOI: doi:10.1093/bja/aet588